7H-Indeno[2,1-c]quinolin-7-one, 6-[[2-(dimethylamino)ethyl]amino]-3-hydroxy-, hydrochloride (1:2), 1mg

(2R,3R)-Dibenzyl 2,3-dihydroxysuccinate, 95%, 100g

5-(4-methoxyphenyl)-1H-imidazol-2-amine, 95.0%, 5g

4-Bromo-3-fluorobenzonitrile, 98.0%, 10g

Methyl 2-(2-fluoro-4-hydroxyphenyl)acetate, 95.0%, 5g

Anti-NeuGc Polyclonal Antibody R-PE Conjugate1vial

6-Amino-1-tetralone>98.0%(GC)(T)5g

2,4,6-Tris(benzyloxy)-1,3,5-triazine, 95+%, 5g

2-Butyl-6-phenylpyridine>97.0%(GC)(T)1g

(4-(Benzyloxy)-2-formylphenyl)boronic acid, 95.0%, 5g

2-Bromo-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 100mg

1-(5-amino-1H-tetrazol-1-yl)acetone, 95.0%, 1g

(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride, 97.0%, 10g